New Details on the Revision of USP Chapter 1
Recommendation
25/26 November 2025
Nitrogen, Compressed Air, Pure Steam
Register now for ECA's GMP Newsletter
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
05.11.2025ECA revises Container-/Closure-Integrity Testing (CCIT) Position Paper
05.11.2025Ozone Concentration during the Sanitization of PW and WFI Systems
29.10.2025Is Surface Roughness in Pure Steam Systems relevant to GMP?
01.10.2025Different Sanitation Strategies for Sections of a WFI Systems?
24.09.2025Warning Letter due to Particles in Infusion Bags
24.09.2025New USP Chapter on oral Dosage Forms